Virus Counter® Plus Platform Enables Fast and Precise Quantification of Lentiviral Vectors
R. Montange, Poorni Adikaram, T. Frazier et al.
· 1 citation
We have 3 of 3 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Jul 2026
Electroacupuncture-mediated lncRNA TUG1 regulates the miR-127-3p/NF-κB p65 axis to inhibit IBS-D low-grade intestinal inflammation
The findings suggest the TUG1/miR-127/NF-κB axis as a candidate therapeutic target for EA in IBS-D, which alleviates low-grade intestinal inflammation and visceral hypersensitivity in IBS-D rats.
Kui-Wu Li, Jiaojiao Wang, Ling Zou et al.
· Frontiers in Immunology · 0 citations
Open access
Jul 2026
Establishment of a scalable engineered cell-line platform for direct, GMP-grade production of eVLP vectors enabling streamlined generation of gene-edited CAR-T/NK cells
An industrial-grade platform based on monoclonal producer cell lines that enables the continuous and scalable generation of engineered virus-like particles (eVLPs) co-packaging Cas9–gRNA ribonucleoproteins (RNPs) and provides a GMP-compliant and broadly adaptable strategy for the streamlined manufacturing of next-gener...
Wei Lin, Jia-Ru Shi, Hanyi Chen et al.
· Frontiers in Immunology · 0 citations